Methylglyoxal products in pre-symptomatic type 1 diabetes

Overview of attention for article published in Frontiers in endocrinology, January 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 7,939 followers.

RT @HatragyiSafarne: Methylglyoxal products in pre-symptomatic type 1 diabetes. 👇 https://t.co/zZWuisIbNy

24 Jan 2023

Reply Repost Favourite

RT @HatragyiSafarne: Methylglyoxal products in pre-symptomatic type 1 diabetes. 👇 https://t.co/zZWuisIbNy

19 Jan 2023

Reply Repost Favourite

New Research: Methylglyoxal products in pre-symptomatic type 1 diabetes: Introduction Progression to type 1 diabetes has emerged as a complex process with metabolic alterations proposed to be a significant driver of disease.… https://t.co/zIxw6YOlep #Endo

19 Jan 2023

Reply Repost Favourite

RT @HatragyiSafarne: Methylglyoxal products in pre-symptomatic type 1 diabetes. 👇 https://t.co/zZWuisIbNy

05 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.